Emil Zhang

Associate | They/Them

Overview

Emil Zhang is an associate in the Antitrust and Competition and Health Care groups based in the firm’s Washington, D.C. office. Emil’s practice encompasses complex antitrust litigation, health care antitrust, counseling, and investigations. Collaborating closely with colleagues, Emil delivers client-centric solutions in the dynamic legal landscapes of antitrust and health care.

In their antitrust practice, Emil diligently advocates for clients in actions relating to anticompetitive practices, such as monopolization and reverse payment settlements, under both federal and state antitrust laws. Within the health care sector, Emil represents managed care organizations, insurers, and health care providers in various regulatory and litigation matters.

Emil received their J.D., cum laude, from Georgetown University Law Center in 2025, where they served as notes editor for the American Criminal Law Review and was a member of the Asian Pacific American Law Students Association. During law school, Emil interned for U.S. District Judge Rudolph Contreras in the U.S. District Court for the District of Columbia. They received their B.A. in Economics and Philosophy, Politics, and Law, from Emory University in 2022.

Career & Education

    • U.S. District Court for the District of Columbia
      Judicial Intern, Honorable Rudolph Contreras, 2025
    • Maryland
      Law Clerk, Office of the Attorney General, 2023
    • U.S. District Court for the District of Columbia
      Judicial Intern, Honorable Rudolph Contreras, 2025
    • Maryland
      Law Clerk, Office of the Attorney General, 2023
    • Emory University, B.A., Phi Beta Kappa, Economics and Philosophy, Politics, and Law, 2022
    • Georgetown University Law Center, J.D., cum laude, 2025
    • Emory University, B.A., Phi Beta Kappa, Economics and Philosophy, Politics, and Law, 2022
    • Georgetown University Law Center, J.D., cum laude, 2025
    • District of Columbia
    • District of Columbia

Emil's Insights

Blog Post | 07.17.26

FTC Blog Updates (July 6-July 10, 2026)

This week the Federal Trade Commission (FTC) issued warning letters to companies making allegedly questionable “Made in the USA” claims, sent more than $2.7 million in payments to workers allegedly harmed by Handy Technologies’ deceptive earnings claims, and announced a $2.25 million settlement with tenant screening company RentGrow. These consumer protection updates reflect the agency’s continued focus on advertising claims, worker-compensation disclosures, and the accuracy of consumer reporting. More on these stories after the jump....

Emil's Insights

Blog Post | 07.17.26

FTC Blog Updates (July 6-July 10, 2026)

This week the Federal Trade Commission (FTC) issued warning letters to companies making allegedly questionable “Made in the USA” claims, sent more than $2.7 million in payments to workers allegedly harmed by Handy Technologies’ deceptive earnings claims, and announced a $2.25 million settlement with tenant screening company RentGrow. These consumer protection updates reflect the agency’s continued focus on advertising claims, worker-compensation disclosures, and the accuracy of consumer reporting. More on these stories after the jump....